Researcher
Jeroen Dekervel
- Disciplines:Analysis of next-generation sequence data, Single-cell data analysis, Cancer diagnosis, Cancer therapy
Affiliations
- Digestive Oncology (Division)
Member
From1 Aug 2022 → Today - Clinical Digestive Oncology (Division)
Member
From1 Oct 2018 → Today - Hepatology (Division)
Member
From1 Oct 2012 → 2 Oct 2016
Projects
1 - 7 of 7
- Neoadjuvant therapy in the treatment of esophageal adenocarcinoma: one size doesn’t fit allFrom14 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Multicenter validation trial of [18F]AlF-FAPI-74 for PET imaging of cancer-associated fibroblasts through fibroblast activation protein inhibitors (FAPI) in digestive tumorsFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Validation, refinement and spatial orientation of CD45RA effector-memory CD8 T-cells and PDL1- expressing CXCL10+ macrophages as predictive markers for response to immune checkpoint inhibition in advanced hepatocellular carcinoma.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- [18F]AlF-NOTA-octreotide PET imaging of the somatostatin receptor in neuroendocrine tumors: comparison with [68Ga]Ga-DOTATATE and evaluation of routine clinical use.From3 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Personalized multimodal treatment for resectable esophageal cancer by detecting minimal residual disease (MRD) using circulating tumor DNA (ctDNA):From11 Jan 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- SAFIR-ABC10: molecular screening for precision medicine in advanced biliary cancersFrom1 Jan 2022 → TodayFunding: Foundations, funds and other with scientific goal
- The search for biomarkers in systemic treatment of advanced hepatocellular carcinoma.From1 Oct 2019 → 1 Oct 2023Funding: FWO Strategic Basic Research Grant
Publications
21 - 30 of 58
- Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study(2022)
Authors: Lien Smets, Albert Wolthuis, Jeroen Dekervel, Christophe Deroose, Xavier Sagaert, Karin Haustermans
Pages: 113 - 120 - Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies(2022)
Authors: Niloefar Ahmadi Bidakhvidi, Karolien Goffin, Jeroen Dekervel, Kristof Baete, Kristiaan Nackaerts, Paul Clement, Chris Verslype, Christophe Deroose
- Prevalence of microsatellite instable and Epstein-Barr Virus-driven gastro-esophageal cancer in a large Belgian cohort(2022)
Authors: Xavier Sagaert, Hilde Brems, Carlijn Brekelmans, Philippe Nafteux, Baki Topal, Chris Verslype, Sabine Tejpar, Jeroen Dekervel
- [68Ga]Ga-DOTATATE-avid tumor volume, uptake and inflammation-based index correlate with survival in neuroendocrine tumor patients treated with [177Lu]Lu-DOTATATE PRRT(2022)
Authors: Jeroen Dekervel, Chris Verslype, Paul Clement, Christophe Dooms, Kristof Baete, Karolien Goffin, Koen Van Laere, Christophe Deroose
Pages: 152 - 162 - A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy(2021)
Authors: Cédric Draulans, Eric Van Cutsem, Gert De Meerleer, Sabine Tejpar, Jeroen Dekervel, Karin Haustermans
Pages: 1121 - 1125 - Evaluating the accuracy of three international guidelines in identifying the risk of malignancy in pancreatic cysts: a retrospective analysis of a surgical treated population(2021)
Authors: Halit Topal, Tania Roskams, Birgit Weynand, Jeroen Dekervel, Eric Van Cutsem, Hannah van Malenstein, Chris Verslype, Wim Laleman, Schalk Van der Merwe
Pages: 443 - 450 - A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatment(2020)
Authors: Jeroen Dekervel
Pages: 1774 - 1783 - [18F]AlF-NOTA-octreotide PET imaging: biodistribution, dosimetry and first comparison with [68Ga]Ga-DOTATATE in neuroendocrine tumour patients(2020)
Authors: Elin Pauwels, Frederik Cleeren, Michel Koole, Jeroen Dekervel, Eric Van Cutsem, Chris Verslype, Koen Van Laere, Guy Bormans, Christophe Deroose
Pages: 3033 - 3046 - Could Autoimmune Disease Contribute to the Abscopal Effect in Metastatic Hepatocellular Carcinoma?(2020)
Authors: Karin Haustermans, Christophe Deroose, Dirk Vanbeckevoort, Chris Verslype, Jeroen Dekervel
Pages: 1152 - 1154 - Quantitative comparison of pre-treatment predictive and post-treatment measured dosimetry for selective internal radiation therapy using cone-beam CT for tumor and liver perfusion territory definition(2020)
Authors: Xikai Tang, Geert Maleux, Jeroen Dekervel, Eric Van Cutsem, Chris Verslype, Kristof Baete, Johan Nuyts, Christophe Deroose